Matthew Durdy appointed to CEO role as the CGT Catapult prepares to accelerate innovation, growth and productivity, where needed in the UK.
The Board of the Cell and Gene Therapy Catapult (CGT Catapult), a global leader in the field of advanced therapies, announced today that its new Chief Executive Officer will be Matthew Durdy, who is currently the Chief Business Officer of the organisation. The appointment will be effective from the beginning of April 2020. This comes after a formal external and internal recruitment process that was initiated after the announcement last October that Keith Thompson, the founding CEO, would be retiring in the spring of 2020.
The Board advertised for applicants who had deep sector experience; could inspire the confidence of the CGT Catapult’s diverse stakeholders; took a perspective of the industry as a global business; were strategic thinkers with a demonstrated track record of relationship building and negotiation; and, had a strong track record of leadership and financial management.
The appointment comes as the cell and gene therapy focussed organisation employs nearly 250 experts orientated around three key areas: manufacturing and supply chain; industrialisation and new technology development; and, global scale clinical adoption practices and product design. The core strategy will continue, and the organisation is prepared for further expansion of the industry and successfully meeting the increasing demands for innovation to drive growth and productivity.
About Matthew Durdy
Part of the 2012 team that created the CGT Catapult, he is also an Executive Director. As Chief Business Officer he has been responsible for strategy; and finding, funding and transacting the business of the CGT Catapult. He is credited with the design and implementation of the commercial model for the highly successful CGT Catapult manufacturing centre and being a global champion for the early integration of healthcare economics and reimbursement expertise into decision-making and clinical product design.